FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between G R Infraprojects IPO and Tatva Chintan Pharma IPO.
G R Infraprojects IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tatva Chintan Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
G R Infraprojects IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Equirus Capital Private Limited Hdfc Bank Limited ICICI Securities Limited Kotak Mahindra Capital Company Limited Motilal Oswal Investment Advisors Limited SBI Capital Markets Limited |
ICICI Securities Limited Jm Financial Limited |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of G R Infraprojects IPO is up to ₹963.28 Cr whereas the issue size of the Tatva Chintan Pharma IPO is up to ₹500.00 Cr. The final issue price of G R Infraprojects IPO is ₹837.00 per share and of Tatva Chintan Pharma IPO is ₹1,083.00 per share.
G R Infraprojects IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Face Value | ₹5 per share | ₹10 per share |
Issue Price (Lower) | ₹828.00 per share | ₹1,073.00 per share |
Issue Price (Upper) | ₹837.00 per share | ₹1,083.00 per share |
Issue Price (Final) | ₹837.00 per share | ₹1,083.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹42.00 per share | |
Market Lot Size | 17 shares | 13 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹225.00 Cr | |
OFS Issue Size | 1,15,08,704 shares | |
OFS Issue Size (Amount) | up to ₹963.28 Cr | up to ₹275.00 Cr |
Issue Size Total | 1,15,08,704 shares | |
Issue Size Total (Amount) | up to ₹963.28 Cr | up to ₹500.00 Cr |
G R Infraprojects IPO opens on Jul 07, 2021, while Tatva Chintan Pharma IPO opens on Jul 16, 2021. The closing date of G R Infraprojects IPO and Tatva Chintan Pharma IPO is Jul 09, 2021, and Jul 20, 2021, respectively.
G R Infraprojects IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jul 07, 2021 | Jul 16, 2021 |
Issue Close | Jul 09, 2021 | Jul 20, 2021 |
Basis Of Allotment (Tentative) | Jul 14, 2021 | Jul 26, 2021 |
Initiation of Refunds (Tentative) | Jul 15, 2021 | Jul 27, 2021 |
Credit of Share (Tentative) | Jul 16, 2021 | Jul 28, 2021 |
Listing date (Tentative) | Jul 19, 2021 | Jul 29, 2021 |
Anchor Lockin End date 1 | Aug 13, 2021 | Aug 25, 2021 |
Anchor Lockin End date 2 | Oct 12, 2021 | Oct 24, 2021 |
G R Infraprojects IPO P/E ratio is , as compared to Tatva Chintan Pharma IPO P/E ratio of .
G R Infraprojects IPO | Tatva Chintan Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 88.04% | 100% | ||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 86.54% | 79.17% | ||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the G R Infraprojects IPO retail investors (RII) are offered 39,49,297 shares while in Tatva Chintan Pharma IPO retail investors are offered 39,49,297 shares. Qualified institutional buyers (QIB) are offered 56,41,851 shares in G R Infraprojects IPO and 9,31,966 shares in Tatva Chintan Pharma IPO.
G R Infraprojects IPO | Tatva Chintan Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 56,41,851 shares | 9,31,966 shares |
NII | 16,92,556 shares | 6,98,975 shares |
RII | 39,49,297 shares | 16,30,941 shares |
Employee | 2,25,000 shares | 0 shares |
Others | ||
Total | 1,15,08,704 shares | 32,61,882 shares |
G R Infraprojects IPO subscribed 102.58x in total, whereas Tatva Chintan Pharma IPO subscribed 180.36x.
G R Infraprojects IPO | Tatva Chintan Pharma IPO | |
---|---|---|
QIB (times) | 168.58x | 185.23x |
NII (times) | 238.04x | 512.22x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 12.57x | 35.35x |
Employee (times) | 1.37x | |
Other (times) | ||
Total (times) | 102.58x | 180.36x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|